Pembrolizumab as second or further line treatment in relapsed malignant pleural mesothelioma: A Swiss registry
Mauti, L.A., Klingbiel, D., Schmid, S., Bouchaab, H., Bartnick, T., Gautschi, O., Rothschild, S.I., Loeffler, M., Froesch, P., Petrausch, U., Wolleb Schild, S., Mingrone, W., Pratsch Peter, S., Savic Prince, S., Pless, M., von Moos, R., Metaxas, Y.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article